A prospective phase IV, multicentre, placebo-controlled study to demonstrate changes in the quality of life following Dysport [botulinum toxin A] intramuscular injection in the treatment of upper limb spasticity in adult post-stroke patients

Trial Profile

A prospective phase IV, multicentre, placebo-controlled study to demonstrate changes in the quality of life following Dysport [botulinum toxin A] intramuscular injection in the treatment of upper limb spasticity in adult post-stroke patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2008

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Muscle spasticity
  • Focus Therapeutic Use
  • Sponsors Ipsen
  • Most Recent Events

    • 25 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top